Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mitja Rot"'
Autor:
Tine Plato Kuhlmann, Elisabeth Dequeker, Mitja Rot, Yann Van Royen, Patrick Pauwels, Sophie Cotteret, Anne Brysse, Siegrid Pauwels, Ilse Van Hee, Brendan O'Sullivan, Cleo Keppens, Nancy Vanderheyden, Estrid Høgdall
Publikováno v:
Archives of pathology and laboratory medicine
Archives of pathology & laboratory medicine, vol. 145, pp. 1-10, 2021.
Keppens, C, van Royen, Y, Brysse, A, Cotteret, S, Høgdall, E, Kuhlmann, T P, O'Sullivan, B, Pauwels, P, Pauwels, S, Rot, M, Vanderheyden, N, van Hee, I & Dequeker, E M C 2021, ' Incidents in molecular pathology : Frequency and causes during routine testing ', Archives of Pathology and Laboratory Medicine, vol. 145, no. 10, pp. 1270-1279 . https://doi.org/10.5858/arpa.2020-0152-OA
Archives of pathology & laboratory medicine, vol. 145, pp. 1-10, 2021.
Keppens, C, van Royen, Y, Brysse, A, Cotteret, S, Høgdall, E, Kuhlmann, T P, O'Sullivan, B, Pauwels, P, Pauwels, S, Rot, M, Vanderheyden, N, van Hee, I & Dequeker, E M C 2021, ' Incidents in molecular pathology : Frequency and causes during routine testing ', Archives of Pathology and Laboratory Medicine, vol. 145, no. 10, pp. 1270-1279 . https://doi.org/10.5858/arpa.2020-0152-OA
Context.— Errors in laboratory medicine could compromise patient safety. Good laboratory practice includes identifying and managing nonconformities in the total test process. Varying error percentages have been described in other fields but are lac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5059bbc36f6a943a2a72dd5040d40e99
https://lirias.kuleuven.be/handle/20.500.12942/707148
https://lirias.kuleuven.be/handle/20.500.12942/707148
Autor:
Markus Rechsteiner, Beatriz Bellosillo, Linea Cecilie Melchior, Linda Lind, Ernest Nadal, Nicol Trincheri, Mitja Rot, Estelle Taranchon-Clermont, E. J. Speel, Guido M.J.M. Roemen, Sebastian Dintner, Christina Frykman, Yun-Chung Nam-Apostolopoulos, Mary Jones, Emma Andrew, Mar Varela-Rodriguez, Sandra N. Freiberger, Izidor Kern, Jennifer Ridgway, Isabelle Rouquette, Samuel Murray, Solène M. Evrard, Klaus H. Wiedorn
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Journal of Molecular Diagnostics, 21(6), 1010-1024. Elsevier Science
Journal of Molecular Diagnostics
Journal of Molecular Diagnostics, American Society for Investigative Pathology (ASIP), 2019, 21, pp.1010-1024. ⟨10.1016/j.jmoldx.2019.06.010⟩
Universidad de Barcelona
Journal of Molecular Diagnostics, 21(6), 1010-1024. Elsevier Science
Journal of Molecular Diagnostics
Journal of Molecular Diagnostics, American Society for Investigative Pathology (ASIP), 2019, 21, pp.1010-1024. ⟨10.1016/j.jmoldx.2019.06.010⟩
Before initiating treatment of advanced non-small-cell lung cancer with tyrosine kinase inhibitors (eg, erlotinib, gefitinib, osimertinib, and afatinib), which inhibit the catalytic activity of epidermal growth factor receptor (EGFR), clinical guidel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42334e133c382caa8138db24cf398906
https://cris.maastrichtuniversity.nl/en/publications/7a35cb16-9c32-4222-af99-4f1cc8e84012
https://cris.maastrichtuniversity.nl/en/publications/7a35cb16-9c32-4222-af99-4f1cc8e84012
Publikováno v:
Journal of Thoracic Oncology. 14:S557-S558
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44b17789eb150c7657cf675c87dff4a4
https://doi.org/10.1016/j.jtho.2019.08.1165
https://doi.org/10.1016/j.jtho.2019.08.1165
Publikováno v:
Journal of Thoracic Oncology. 12:S388-S389
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71d2af483a10e2eeec5cf1d7d10ec14c
https://doi.org/10.1016/j.jtho.2016.11.440
https://doi.org/10.1016/j.jtho.2016.11.440
Publikováno v:
Journal of Thoracic Oncology. 12:S491
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82ebbfabeb6b40c7d962d12529112659
https://doi.org/10.1016/j.jtho.2016.11.591
https://doi.org/10.1016/j.jtho.2016.11.591
Publikováno v:
Journal of Thoracic Oncology. 11:S123
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2ed1f828beb9d97f9e609d17ba076b2
https://doi.org/10.1016/s1556-0864(16)30260-x
https://doi.org/10.1016/s1556-0864(16)30260-x
Autor:
Karmen Stanic, Tanja Cufer, Nina Turnsek, Mitja Rot, Aleksander Sadikov, Matjaz Zwitter, Izidor Kern
Publikováno v:
Journal of Clinical Oncology. 32:8096-8096
8096 Background: ActivatingEGFR mutations (EGFRmu), especially exon 19 deletions (del 19) and L858R point mutation in exon 21 are best predictors of response to TKI therapy in advanced non-small ce...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad58775d4adeaa6342a508759280fef1
https://doi.org/10.1200/jco.2014.32.15_suppl.8096
https://doi.org/10.1200/jco.2014.32.15_suppl.8096